يعرض 1 - 10 نتائج من 63 نتيجة بحث عن '"tacrolimus/dt [Drug Therapy]"', وقت الاستعلام: 0.95s تنقيح النتائج
  1. 1
    مورد إلكتروني
  2. 2
    مورد إلكتروني
  3. 3
  4. 4
    مورد إلكتروني

    مصطلحات الفهرس: psoriatic arthritis/di [Diagnosis], psoriatic arthritis/dt [Drug Therapy], rheumatic disease, rheumatoid arthritis/di [Diagnosis], rheumatoid arthritis/dt [Drug Therapy], rheumatology, scleroderma/di [Diagnosis], scleroderma/dt [Drug Therapy], social acceptance, spondylarthritis/di [Diagnosis], spondylarthritis/dt [Drug Therapy], systemic lupus erythematosus/di [Diagnosis], systemic lupus erythematosus/dt [Drug Therapy], telehealth, therapeutic misconception, vasculitis/di [Diagnosis], vasculitis/dt [Drug Therapy], abatacept/dt [Drug Therapy], azathioprine/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], cyclosporine/dt [Drug Therapy], hydroxychloroquine/dt [Drug Therapy], Janus kinase inhibitor/dt [Drug Therapy], leflunomide/dt [Drug Therapy], methotrexate/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], nonsteroid antiinflammatory agent/dt [Drug Therapy], prednisolone/dt [Drug Therapy], rituximab/dt [Drug Therapy], salazosulfapyridine/dt [Drug Therapy], secukinumab/dt [Drug Therapy], tacrolimus/dt [Drug Therapy], tocilizumab/dt [Drug Therapy], tumor necrosis factor inhibitor/dt [Drug Therapy], ustekinumab/dt [Drug Therapy], infection control, adult, article, controlled study, coronavirus disease 2019/di [Diagnosis], coronavirus disease 2019/dt [Drug Therapy], disease course, disease severity, drug use, female, health survey, human, major clinical study, male, medical information, middle aged, pandemic, patient participation, patient risk, perception, Article

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29085Test
    Arthritis Care and Research
    Click here for full text options
    LibKey Link

  5. 5
    مورد إلكتروني

    مصطلحات الفهرس: Crohn disease/th [Therapy], dendritic cell, DNA immunization, DNA vector, drug targeting, effector cell, fecal microbiota transplantation, graft rejection, immunological tolerance, insulin dependent diabetes mellitus/dt [Drug Therapy], insulin dependent diabetes mellitus/et [Etiology], low drug dose, microbiome, multiple sclerosis/et [Etiology], nonhuman, pemphigus/th [Therapy], phenotype, regulatory T lymphocyte, review, skin lupus erythematosus/th [Therapy], synergistic effect, systemic lupus erythematosus/et [Etiology], T lymphocyte subpopulation, transient expression, treatment outcome, umbilical cord blood, aldesleukin/dt [Drug Therapy], autoantigen, bacterial polysaccharide, beta glucan, butyric acid, CD135 antigen, chimeric antigen receptor/ec [Endogenous Compound], corticosteroid/dt [Drug Therapy], cytokine receptor agonist/dt [Drug Therapy], cytokine receptor agonist/pd [Pharmacology], cytotoxic T lymphocyte antigen 4/ec [Endogenous Compound], Flt3 ligand/cb [Drug Combination], Flt3 ligand/it [Drug Interaction], Flt3 ligand/dt [Drug Therapy], galactan, immunosuppressive agent/dt [Drug Therapy], insulin/dt [Drug Therapy], interleukin 10/dt [Drug Therapy], interleukin 10/pd [Pharmacology], major histocompatibility antigen/ec [Endogenous Compound], mammalian target of rapamycin/ec [Endogenous Compound], mammalian target of rapamycin inhibitor/dt [Drug Therapy], mammalian target of rapamycin inhibitor/pd [Pharmacology], methylprednisolone/do [Drug Dose], methylprednisolone/dt [Drug Therapy], mycophenolic acid/do [Drug Dose], mycophenolic acid/dt [Drug Therapy], nanoparticle, peptide/dt [Drug Therapy], rapamycin/cb [Drug Combination], rapamycin/it [Drug Interaction], rapamycin/dt [Drug Therapy], rapamycin/pd [Pharmacology], recombinant interleukin 2/do [Drug Dose], recombinant interleukin 2/dt [Drug Therapy], short chain fatty acid, T lymphocyte receptor/ec [Endogenous Compound], tacrolimus/do [Drug Dose], tacrolimus/dt [Drug Therapy], transcription factor FOXP3/ec [Endogenous Compound], tumor necrosis factor receptor 2/ec [Endogenous Compound], unclassified drug, tumor necrosis factor receptor 2 agonist/dt [Drug Therapy], tumor necrosis factor receptor 2 agonist/pd [Pharmacology], human, adverse event, antigen specificity, antiinflammatory activity, autoimmune disease/dt [Drug Therapy], autoimmune disease/et [Etiology], autoimmune disease/pc [Prevention], autoimmune disease/th [Therapy], autoimmune hepatitis/th [Therapy], autoimmunity, Bifidobacterium bifidum, biological therapy, CD4+ T lymphocyte, cell therapy, chimeric antigen receptor immunotherapy, chronic inflammation, Review

    URL: International Journal of Molecular Sciences
    Click here for full text options
    LibKey Link

  6. 6
  7. 7
    مورد إلكتروني

    مصطلحات الفهرس: psoriatic arthritis/di [Diagnosis], psoriatic arthritis/dt [Drug Therapy], rheumatic disease, rheumatoid arthritis/di [Diagnosis], rheumatoid arthritis/dt [Drug Therapy], rheumatology, scleroderma/di [Diagnosis], scleroderma/dt [Drug Therapy], social acceptance, spondylarthritis/di [Diagnosis], spondylarthritis/dt [Drug Therapy], systemic lupus erythematosus/di [Diagnosis], systemic lupus erythematosus/dt [Drug Therapy], telehealth, therapeutic misconception, vasculitis/di [Diagnosis], vasculitis/dt [Drug Therapy], abatacept/dt [Drug Therapy], azathioprine/dt [Drug Therapy], cyclophosphamide/dt [Drug Therapy], cyclosporine/dt [Drug Therapy], hydroxychloroquine/dt [Drug Therapy], Janus kinase inhibitor/dt [Drug Therapy], leflunomide/dt [Drug Therapy], methotrexate/dt [Drug Therapy], mycophenolic acid/dt [Drug Therapy], nonsteroid antiinflammatory agent/dt [Drug Therapy], prednisolone/dt [Drug Therapy], rituximab/dt [Drug Therapy], salazosulfapyridine/dt [Drug Therapy], secukinumab/dt [Drug Therapy], tacrolimus/dt [Drug Therapy], tocilizumab/dt [Drug Therapy], tumor necrosis factor inhibitor/dt [Drug Therapy], ustekinumab/dt [Drug Therapy], infection control, adult, article, controlled study, coronavirus disease 2019/di [Diagnosis], coronavirus disease 2019/dt [Drug Therapy], disease course, disease severity, drug use, female, health survey, human, major clinical study, male, medical information, middle aged, pandemic, patient participation, patient risk, perception, Article

  8. 8
    مورد إلكتروني

    مصطلحات الفهرس: Crohn disease/th [Therapy], dendritic cell, DNA immunization, DNA vector, drug targeting, effector cell, fecal microbiota transplantation, graft rejection, immunological tolerance, insulin dependent diabetes mellitus/dt [Drug Therapy], insulin dependent diabetes mellitus/et [Etiology], low drug dose, microbiome, multiple sclerosis/et [Etiology], nonhuman, pemphigus/th [Therapy], phenotype, regulatory T lymphocyte, review, skin lupus erythematosus/th [Therapy], synergistic effect, systemic lupus erythematosus/et [Etiology], T lymphocyte subpopulation, transient expression, treatment outcome, umbilical cord blood, aldesleukin/dt [Drug Therapy], autoantigen, bacterial polysaccharide, beta glucan, butyric acid, CD135 antigen, chimeric antigen receptor/ec [Endogenous Compound], corticosteroid/dt [Drug Therapy], cytokine receptor agonist/dt [Drug Therapy], cytokine receptor agonist/pd [Pharmacology], cytotoxic T lymphocyte antigen 4/ec [Endogenous Compound], Flt3 ligand/cb [Drug Combination], Flt3 ligand/it [Drug Interaction], Flt3 ligand/dt [Drug Therapy], galactan, immunosuppressive agent/dt [Drug Therapy], insulin/dt [Drug Therapy], interleukin 10/dt [Drug Therapy], interleukin 10/pd [Pharmacology], major histocompatibility antigen/ec [Endogenous Compound], mammalian target of rapamycin/ec [Endogenous Compound], mammalian target of rapamycin inhibitor/dt [Drug Therapy], mammalian target of rapamycin inhibitor/pd [Pharmacology], methylprednisolone/do [Drug Dose], methylprednisolone/dt [Drug Therapy], mycophenolic acid/do [Drug Dose], mycophenolic acid/dt [Drug Therapy], nanoparticle, peptide/dt [Drug Therapy], rapamycin/cb [Drug Combination], rapamycin/it [Drug Interaction], rapamycin/dt [Drug Therapy], rapamycin/pd [Pharmacology], recombinant interleukin 2/do [Drug Dose], recombinant interleukin 2/dt [Drug Therapy], short chain fatty acid, T lymphocyte receptor/ec [Endogenous Compound], tacrolimus/do [Drug Dose], tacrolimus/dt [Drug Therapy], transcription factor FOXP3/ec [Endogenous Compound], tumor necrosis factor receptor 2/ec [Endogenous Compound], unclassified drug, tumor necrosis factor receptor 2 agonist/dt [Drug Therapy], tumor necrosis factor receptor 2 agonist/pd [Pharmacology], human, adverse event, antigen specificity, antiinflammatory activity, autoimmune disease/dt [Drug Therapy], autoimmune disease/et [Etiology], autoimmune disease/pc [Prevention], autoimmune disease/th [Therapy], autoimmune hepatitis/th [Therapy], autoimmunity, Bifidobacterium bifidum, biological therapy, CD4+ T lymphocyte, cell therapy, chimeric antigen receptor immunotherapy, chronic inflammation, Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29021Test
    International Journal of Molecular Sciences
    LibKey Link

  9. 9
    مورد إلكتروني
  10. 10
    مورد إلكتروني